Full Press Release Details
Lexaria announces ViPovaTM Website
for CBD Research and Direct Tea Sales
Kelowna, BC / January 15, 2015 / Lexaria, Corp. (LXRP)
(CSE:LXX) (the Company ) announces that ViPovaTM by Lexaria has
launched a new website at www.vipova.com The
new site is live and contains research on tea, cannabinoids (CBD) and
Consumers across all 50 states can now buy America s FIRST
product that uses patent-pending technology to infuse CBDs within lipids for the
most comforting and effective experience possible.
The new www.vipova.com
website will take your orders now and we have ViPovaTM Tea
in-stock and ready to ship today. Customers can also call 1-888-976-8482 from
9AM to 7PM EST Mon-Fri to place their orders. We are not yet ready to accept
credit cards as payment, but expect to be able to add that feature soon.
For a limited time only, we have two introductory offers to
thank our first customers:
Our earliest customers will receive a coupon with their first
order of ViPovaTM Tea: the coupon is good for 30% off your second
order, and your second order can be any size you like. Only one coupon will
be available to each customer. Also for a limited time, get free shipping
anywhere in the USA for your tea order we pay the cost of delivering the tea
to you. www.vipova.com is more than just the
first online location to sell ViPovaTM Tea. It is also a leading
location for research on cannabinoids, allowing visitors to learn for themselves
of the many studies already conducted on CBD s. Research will be regularly
updated and broadened and everyone is encouraged to visit to learn of the
wondrous properties of cannabidiol.
We also are launching an online community and blog at the
website; users will have the opportunity to share their personal experiences
with the therapeutic and wellness effects of cannabinoids and customer
experiences with ViPova Tea. Over time we hope that users will share knowledge,
recipes and other information.
As well, ViPovaTM co-founder and consultant to
Lexaria Dr. Michelle Reillo, will write a regular blog feature available only at
www.vipova.com, sharing her extensive
knowledge on the endocannabinoid system and how her research has suggesting that
good overall health is perhaps not possible when the endocannabinoid system is
compromised or weakened.
It is our hope that over time, www.vipova.com will become the leading portal for
knowledge, research, personal experiences and, of course, a venue to purchase
products from VipovaTM all related to cannabinoids.
Lexaria's shares are quoted in the USA with
symbol LXRP and in Canada with symbol LXX. The company searches for projects
that could provide potential above-market returns.
ViPovaTM uses only legal CBD oil extracts, grown
from legal hemp in locations where it is legal to do so, in
ViPovaTM-branded tea. ViPovaTM uses its patent-pending
process to infuse concentrated amounts of CBD within lipids in its tea,
providing more bioactivity and comfort to the body during the absorption
process. Only ViPovaTM has this ground-breaking technology for
CBD/lipid infusion. www.vipova.com FOR FURTHER INFORMATION PLEASE CONTACT:
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements
which are not historical facts are forward-looking statements. The Company makes
forward-looking public statements concerning its expected future financial
position, results of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities, plans and
objectives of management for future operations, including statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other similar
expressions are forward-looking statements. Such forward-looking statements are
estimates reflecting the Company's best judgment based upon current information
and involve a number of risks and uncertainties, and there can be no assurance
that other factors will not affect the accuracy of such forward-looking
statements. Access to capital, or lack thereof, is a major risk and there is no
assurance that the Company will be able to raise required working capital.
Current oil and gas production rates may not be sustainable and targeted
production rates may not occur. Factors which could cause actual results to
differ materially from those estimated by the Company include, but are not
limited to, government regulation, managing and maintaining growth, the effect
of adverse publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements and filings.
There is no assurance that the medical marijuana, CBD sector, or alternative
health businesses will provide any benefit to Lexaria, or that the Company will
experience any growth through participation in these sectors. There is no
assurance that existing capital is sufficient for the Company's needs or that it
will need to attempt to raise additional capital. There is no assurance that any
cannabinoid-based product will promote, assist, or maintain any beneficial human
health conditions whatsoever. No statement herein has been evaluated by the Food
and Drug Administration (FDA). ViPovaTM products are not intended to
diagnose, treat, cure or prevent any disease.
The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.